辛伐他汀治疗老年高脂血症176例的临床观察

Simvastatin elderly hyperlipidemia 176 cases of clinical observation

高脂血症是动脉粥样硬化、冠心病和脑血管疾病的重要致病因素,血清总胆固醇(TC)、甘油三酯(TG)和低密度脂蛋白胆固醇(LDL-C)升高是冠心病的独立危险因素。纠正高脂血症,有利于减少或延缓动脉粥样硬化的发生和发展,从而降低心、脑血管事件的发生率。流行病学研究及循证医学证据显示,调脂治疗对心血管疾病有益。他汀类调脂药被临床认可的高效的调脂药物,不但具有降低血清总胆固醇和低密度脂蛋白胆固醇的作用,而且还有明确的降低甘油三酯的作用。现将门诊2008年1月至2009年12月应用中等剂量辛伐他汀治疗老年高脂血症176例的结果报道如下。

Hyperlipidemia atherosclerosis and coronary heart disease is the important and cerebrovascular diseases pathogenic factors,serum total cholesterol（TC）,triglyceride（TG） and low density lipoprotein cholesterol（LDL-C） is independent risk factors for coronary heart disease（CHD）.Correct hyperlipidemia,be helpful for reducing or delay atherosclerosis and development,so as to reduce the incidence of heart,cerebrovascular event.Epidemiological studies and evidence-based medicine in the treatment of evidence,lipid of cardiovascular disease.Statin drugs approved by tiaozhi clinical efficient of lipid drugs,not only has reduced serum total cholesterol,low density lipoprotein cholesterol and function,but also the specific lower triglyceride.Now will clinics in January 2008-2009 December application moderate doses simvastatin 176 patients treated older hyperlipidemia results report below.